Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 385 (RNA5SP385) is classified as a human pseudogene, meaning it is a segment of DNA that resembles the gene for 5S ribosomal RNA but is non-functional and does not encode an active RNA product[1][2][4]. Pseudogenes may arise from duplication or retrotransposition events and typically acquire disabling mutations. The original functional 5S ribosomal RNA plays a structural role within the large ribosomal subunit and is essential for protein synthesis[3][5][7], but pseudogenes of 5S rRNA, such as RNA5SP385, do not contribute to ribosome function. There is no known evidence that RNA5SP385 is involved in any characterized cellular process, disease mechanism, or serves as a therapeutic target. Its presence is documented in genomic databases, but it is not associated with biological activity or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 385 (RNA5SP385).